drugset / Trial / NCT07248163

Universal CAR-T Cell Therapy for NHL

NCT07248163 ↗

NaSingle-groupOpen-labelTreatment

Summary

This is a single-center, single-arm, open-label clinical study, and the sample size is set to 3-6 subjects.

Timeline

Start
2025-03-11
Primary completion
2027-08-15
Completion
2028-03-11

Drugs

EvaluationDrugModalityDoseRoute
Subject BRL-301 Cell therapy 5e+06 cells/kg —